Zobrazeno 1 - 10 of 269 pro vyhledávání: '"G, Roubaud"'
1
Akademický článek
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
Autor: Christian Pfister, Valentin Harter, Yves Allory, François Radvanyi, Stéphane Culine, G. Grawis, G. Pignot, A. Flechon, J.P. Fendler, C. Chevreau, M. Soulie, H. Mahammedi, L. Guy, B. Laguerre, G. Verhoest, A. Guillot, N. Mottet, F. Joly, A. Doerfler, S. Abadie-Lacourtoisie, A.R. Azzouzi, P. Mongiat, L. Geoffrois, P. Eschwege, F. Di Fiore, G. Roubaud, J.L. Hoepffner, P. Barthelemy, H. Lang, E. Voog, E. Mandron, J.M. Tourani, C. Serrrate, A. Colau, C. Saldana, A. de La Taille, T. Nguyen, F. Kleinclauss, Y. Loriot, J. Irani, J.C. Eymard, S. Larre, O. Huillard, M. Zerbib, F. Rolland, J. Rigaud, N. Houede, S. Droupy, G. Malouf, M. Roupret, M. El Demery, C. Legon, S. Vieillot, N. Letang, T. Lharidon, N. Gaschignard, W. Hilgers, J.L. Davin
Publikováno v: Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
The main objective of the French GETUG/AFU V05 VESPER randomized phase III study was to assess the efficacy of dd-MVAC and GC in term of progression-free survival in patients for whom chemotherapy has been decided, before or after surgery.A total of
Externí odkaz: https://doaj.org/article/f43ed578297242ffbca2d23538b428ab
Zobrazit plný text záznamu
3
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients
Autor: A, Bessede, A, Marabelle, J P, Guégan, F X, Danlos, S, Cousin, F, Peyraud, N, Chaput, M, Spalato, G, Roubaud, M, Cabart, M, Khettab, A, Chaibi, C, Rey, I, Nafia, F X, Mahon, J C, Soria, A, Italiano
Publikováno v: Annals of Oncology. 33:909-915
Acetaminophen (APAP) use has been associated with blunted vaccine immune responses. This study aimed to assess APAP impact on immunotherapy efficacy in patients with cancer.Exposure to APAP was assessed by plasma analysis and was correlated with clin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94865c6e05f5e8c885fdcd526cf6175c
https://doi.org/10.1016/j.annonc.2022.05.010
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
Autor: G. Ploussard, G. Fiard, E. Barret, L. Brureau, G. Créhange, C. Dariane, G. Fromont, M. Gauthé, R. Mathieu, R. Renard-Penna, G. Roubaud, F. Rozet, A. Ruffion, P. Sargos, J.-B. Beauval, M. Rouprêt
Publikováno v: Progrès en Urologie
Progrès en Urologie, 2022, 32 (15), pp.1275-1372. ⟨10.1016/j.purol.2022.07.148⟩
International audience; OBJECTIVE: The objective of the French Urology Association Cancer Committee is to propose an update of the recommendations for the diagnosis and management of prostate cancer (PC). METHODS: A systematic review of the literatur
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702db9aad5ba62d25d9b6323d109bd0b
https://hal.science/hal-03889608
Zobrazit plný text záznamu
9
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
Autor: G. Ploussard, G. Roubaud, E. Barret, J.-B. Beauval, L. Brureau, G. Créhange, C. Dariane, G. Fiard, G. Fromont, M. Gauthé, R. Renard-Penna, F. Rozet, A. Ruffion, P. Sargos, R. Mathieu, M. Rouprêt
Publikováno v: Progrès en Urologie
Progrès en Urologie, 2022, 32 (15), pp.1373-1419. ⟨10.1016/j.purol.2022.07.147⟩
International audience; OBJECTIVE: The objective of the French Urology Association Cancer Committee is to propose an update of the recommendations for the management of prostate cancer. METHODS: A systematic review of the literature from 2020 to 2022
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c12500ef3a06be8f6ab64d3c4d7513c
https://hal.science/hal-03889691
Zobrazit plný text záznamu
10
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]
Autor: M, Baboudjian, J-B, Beauval, E, Barret, L, Brureau, G, Créhange, C, Dariane, G, Fiard, G, Fromont, M, Gauthé, R, Mathieu, R, Renard-Penna, G, Roubaud, A, Ruffion, P, Sargos, M, Rouprêt, G, Ploussard
Publikováno v: Progrès en Urologie
Progrès en Urologie, 2022, 32 (10), TT-Avancées récentes dans la prise en charge du cancer de la prostate localisé à. ⟨10.1016/j.purol.2022.04.007⟩
National audience; INTRODUCTION: The risk of recurrence is increased in localized high-risk prostate cancer (PCa). The implementation of an appropriate diagnostic and therapeutic strategy is essential. The objective of this update by the Prostate Com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5db88ba170fb77c8f2de2c5ca67d91a5
https://hal.science/hal-03763624
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje